HonorHealth Research Institute is combining ultra-sound technology with targeted drugs to shrink the tumors of pancreatic cancer patients whose cancer has not spread to other parts of the body but is too advanced for surgical removal.

According to a press release, HonorHealth uses Acoustic Cluster Therapy (ACT), which uses tiny clusters of gas bubbles and oil droplets that make up an FDA-approved cocktail of four drugs that are infused into the bloodstream. High-frequency ultrasound is applied in and around the pancreas tumor which causes the cocktail to form large bubbles that are lodged in the capillaries.

This is followed by a low-frequency ultrasound which induces oscillation of the lodged ACT bubbles, which helps deliver the chemotherapy directly to the cancer before the bubbles eve

See Full Page